Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Expora Therapeutics is a biotechnology company and contract development and manufacturing organization (CDMO) specializing in bacterial extracellular vesicles (BEVs). Spun out of the University of Maryland, the company utilizes a proprietary platform to design and mass-produce oral, gut-restricted, multi-specific BEV immunotherapies. Expora's technology addresses the historical challenges of BEV manufacturing—such as cost, consistency, quality, and scalability—to enable the commercialization of therapeutics for gastrointestinal diseases like inflammatory bowel disease (IBD) and necrotizing enterocolitis. Led by PhD scientists with deep expertise in BEVs, the company offers both proprietary therapeutic candidates and contract services spanning discovery, process development, and GMP manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Expora Therapeutics.